Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (451)

« Back to Publications

Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis From an International Cohort.

Micheletti RG. et al, (2026), International journal of dermatology

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study.

Jayne DRW. et al, (2026), JMIR research protocols, 15

Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis.

Bayindir Y. et al, (2025), RMD open, 11

Vasculitic neuropathy-related disability, pain, quality of life, and autonomic symptoms: a survey of 312 patients.

Collins MP. et al, (2024), Rheumatology (Oxford, England), 63, 2791 - 2798

Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.

Manning JE. et al, (2024), Journal of autoimmunity, 147

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

Grayson PC. et al, (2022), Annals of the Rheumatic Diseases, 81, 1654 - 1660

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

Ponte C. et al, (2022), Annals of the Rheumatic Diseases, 81, 1647 - 1653

2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

Ponte C. et al, (2022), Arthritis & Rheumatology, 74, 1881 - 1889

2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis

Grayson PC. et al, (2022), Arthritis & Rheumatology, 74, 1872 - 1880

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

Grayson PC. et al, (2022), Annals of the rheumatic diseases, 81, 1654 - 1660

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.

Ponte C. et al, (2022), Annals of the rheumatic diseases, 81, 1647 - 1653

Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis.

Gribbons KB. et al, (2020), Arthritis care & research, 72, 1615 - 1624

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease

Goodchild G. et al, (2020), Clinical Medicine, 20, e32 - e39

Early development of new cardiovascular risk factors in the systemic vasculitides.

Monti S. et al, (2020), Clinical and experimental rheumatology, 38 Suppl 124, 126 - 134

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Hellmich B. et al, (2020), Annals of the rheumatic diseases, 79, 19 - 30

Load More

1
2
3
4
5
6
7
...
»